IMCAS 2012 Press Meeting Report : The cosmeto vigilance watcher and the decipherer of the new developments and trends of the profession

1. PRESS MEETING REPORT Paris -­‐ February 2012
IMCAS PRESS OFFICE -­‐ P.B Communication
7 Villa des Sablons 92200 Neuilly sur Seine -­‐ Tel : + 33 1 47 31 11 06 -­‐ E-­‐mail : pbcom@wanadoo.fr
www.imcas.com
1
IMCAS Annual Meeting 2012 report
2012, a top shelf IMCAS congress -­‐ an edition to remember
IMCAS is one of the most important European Courses dedicated to Plastic Surgery and Cosmetic Dermatology. Its main
objective is to promote the highest possible standards in clinical practice, education and research within the plastic surgery
/ dermatology interface, as well as in related disciplines (facial plastic surgery, oculoplastic surgery, aesthetic medicine,
SOFCEP (Société Française des Chirurgiens Esthétiques Plasticiens), the ESLD (European Society for Laser Dermatology) and
the ASDS (American Society for Dermatologic Surgery).
IMCAS 2012 was a very successful edition:
A record attendance
The event welcomed this year more than 4 000 delegates -­‐ representing a true "medical population sampling" from 60
different countries -­‐ more than 160 exhibitors and about 100 accredited journalists from all around the world. This
engendered more than 90 press reviews.
A world Avant Première at the IMCAS
Two brand new workshops took the form of live videoconferences, using cutting edge technology to allow attendees to
witness procedures and to interfere with practitioners.
IMCAS Injectables Cadaver Workshop
and the Breast Lipofilling Workshop on patients.
IMCAS 2012 -­‐ The cosmeto vigilance watcher
Far from consensual lectures and classical conferences talks, the program keynote has been " controversy".
A great deal of scientific sessions was devoted to the subtle topic of complications, and techniques allowing to prevent
them, while others focused on the theme of cosmeto and materio vigilance alerts. Also featured, the results of a worldwide
survey run on the complications of injectables, and their prevention, communicated and commented during a special
session.
The program also offered objective comparative analyses on the products (Hyaluronic acid, toxins, CO2 Laser, implants...)
far from the firms'
In short, IMCAS did not wait for the PIP crisis to make vigilance one of its main concern, and specially this year by
organizing the following sessions:
Sessions comparisons of hyaluronic acids, toxins and lasers, independent from the Industry
Session fillers complications, featuring the results of the first worldwide survey on the topic
Session operative safety in dermatology and plastic surgery
Session European vigilance in dermatologic and surgical aesthetic,
... to which was just added the session dedicated to the PIP crisis

2. PRESS MEETING REPORT Paris -­‐ February 2012
IMCAS PRESS OFFICE -­‐ P.B Communication
7 Villa des Sablons 92200 Neuilly sur Seine -­‐ Tel : + 33 1 47 31 11 06 -­‐ E-­‐mail : pbcom@wanadoo.fr
www.imcas.com
2
IMCAS deciphers the new developments and trends of the profession
More than trends, social phenomenon already
New development axis
Aesthetic surgery: a responsible specialty
On the medical aspect: techniques and products are more and more efficient, especially when it comes to the face, which
does not exclude an increased vigilance to optimise even more the ratio between profits and risks.
The wrinkles fillers, volumetry products and botulinum toxins are a good example: the reinforcements of controls regarding
the entrance market authorization (AMM for Toxins, CE for other medical devices) are already efficient for most of them,
but the necessity of increasing clinical studies preliminary to the products introduction to the market, as well as the
selection of doctors empowered to practice those techniques, are sine qua non conditions in order to limit risks and
misuses.
In 2012, the market presented a two-­‐gears growth, characterized by:
A growth of about 5% in Europe, compared to 2011
And a growth of about 15% in Asia.
Cosmeceutics (active cosmetic) follow that growth trend, and the other classical techniques (peelings, lasers,
radiofrequences...) are even catching up with the decrease of business previously observed within their segment.
Regarding the body, the controls and studies of remodelling devices and medical slimming products have to get through
the same process as the face: the suspension of the decree forbidding any fat lysing method being only a temporary
solution, which will have to lead to good processes, with a better documentation, especially when it comes to phosphatidyl
(a soy derivative) injections, non authorized in France. It is to note than a close molecule, the desoxycholine, is subjected to
a large, serious and multi-­‐centric clinical study in Europe and in the U.S., to treat small double chins.
On the surgical aspect, the slowdown expected in Europe is limited:
Breast implants are subjected to a progression of about 6%, fitting the last data observed those past years. The general
progression for surgery presents 2 gears as well: +7% in Europe against +11,1% in the US but most of all, +15,7% in Asia.
The 2 most popular interventions are still, in the world as well as for each geographical area, the liposuction and the breast
augmentation with prosthetic implants. But the lipofilling knows a more and more important development.
New trends in 2011
The trend for natural: in France, in Europe, in USA and more and more worldwide, the trend imposing itself
nowadays is to restore and maintain at patients a beauty un-­‐stereotyped, without the need to "look young at any
cost".
A more localised surgical lifting: whether it's done for the face, the arms or the internal face of the tights, the
lifting is now less global, less invasive, with shorter scars. The objective is to never nip or tuck against nature and
getting more discreet scars.
Non-­‐invasive therapies: in 2012, important innovations are expected, especially with new toxins, which will appear
on the scientific change within the coming months.
More and more combined techniques: non-­‐invasive techniques are combined to one another, like toxin for the
upper face and hyaluronic acid for the lower face. Moreover, those techniques are not in opposition with surgery
but prepare or maintain the surgical gesture. The treatments are thus more and more combined within a single
and precise therapeutic program.

3. PRESS MEETING REPORT Paris -­‐ February 2012
IMCAS PRESS OFFICE -­‐ P.B Communication
7 Villa des Sablons 92200 Neuilly sur Seine -­‐ Tel : + 33 1 47 31 11 06 -­‐ E-­‐mail : pbcom@wanadoo.fr
www.imcas.com
3
IMCAS as a Talent Scout
With the 2
nd
edition of IMCAS Business Incubator...
The purpose of the IMCAS Incubator, coordinated by Pr. Serge Mordon, PhD, research director of INSERM in Lille, France, is
to enable innovative ideas, techniques and technologies, developed by physicians and not yet submitted for further
evaluation
companies in the aesthetic industry.
A specific session taught attendees how to access relevant clinical, business and capital resources.
Furthermore, the IMCAS Incubator included a Speed Dating Corner, created to optimize and support exchanges between
attendees and the relevant management of the attending industry. Over one hour, at intervals of 15 minutes, innovative
face or body treatment techniques and technologies have been presented to R&D executives from the aesthetic industry.
... And La Nuit des IMCAS Awards
Dedicated to reward some of our best practitioner for their clinical studies/trials, medical or surgical, of 2011. This year, the
jury was composed of:
Professor Louis Casteilla, PhD, from the French National Institute of Health and Medical Research (INSERM),
Director of STROMALab (Inserm, CNRS, Université), representing the Research segment
Dr Gary Monheit, Dermatologist from USA, former president of ASDS (American Society for Dermatologic
Surgery) representing the Dermatology segment
and Dr Foad Nahai, Plastic Surgeon from USA, former president of ISAPS (International Society of Aesthetic Plastic
Surgery) and ASAPS (American Society of Aesthetic Plastic Surgery), representing the Plastic Surgery segment.
Here are the 4 winners anonymously chosen by the jury among the 16 nominees list:
Dr Olga CHERNYSHEVA, Psychologist from Russia (co-­‐author: Dr Sergey MOSHAK) for "Quality of life
enhancement after anti-­‐aging aesthetic surgery."
Dr Bernard MOLE, Plastic Surgeon from France for "«Scratched faces» treatment by highly diluted botulinum
toxin superficial injections."
Dr Aris STERODIMAS, Plastic Surgeon from Greece for "Autologous fat transplantation versus adipose-­‐derived
stem cell-­‐enriched lipografts: a study."
Dr Gilbert ZAKINE, Plastic Surgeon from France for "Chitosan gel improve cutaneous healing: a clinical study on
surgical scars."
Coming up next
In 2012, IMCAS exports itself worldwide once again, with 3 other meetings: IMCAS CHINA (Shanghai) July 28th and 29
th
,
IMCAS ASIA (Hong Kong) October 4
th
to 6
th
and IMCAS INDIA (Mumbai) October 13
th
and 14
th
2012.
Benjamin ASCHER, French Board certified Plastic Surgeon and IMCAS Course Director
The Course Coordinators:
David J GOLDBERG, Dermatologist (United States)
Bernard MOLE, Plastic Surgeon (France)
Bernard ROSSI, Dermatologist, (France)
Follow IMCAS on Twitter @imcascongress
Join IMCAS on Linked In : "IMCAS Congress Open Group"
Find IMCAS on Facebook "IMCAS International Master Course on Aging Skin"
The Scientific Secretaries:
Olivier GERBAULT, Plastic Surgeon (France)
Anne LE PILLOUER PROST, Dermatologist (France)
Serge MORDON, PhD Research (France)